Literature DB >> 31235033

Large No More: The Journey of Pulmonary Large Cell Carcinoma from Common to Rare Entity.

Natasha Rekhtman1, William D Travis2.   

Abstract

Entities:  

Year:  2019        PMID： 31235033     DOI： 10.1016/j.jtho.2019.04.014

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  8 in total

1.  Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma.

Authors:  Klaus J Busam; Natasha Rekhtman; Chen Yang; Francisco Sanchez-Vega; Jason C Chang; Walid K Chatila; Alexander N Shoushtari; Marc Ladanyi; William D Travis
Journal:  Mod Pathol       Date:  2020-06-24       Impact factor: 7.842

Review 2.  Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists.

Authors:  Colin R Lindsay; Emily C Shaw; David A Moore; Doris Rassl; Mariam Jamal-Hanjani; Nicola Steele; Salma Naheed; Craig Dick; Fiona Taylor; Helen Adderley; Fiona Black; Yvonne Summers; Matt Evans; Alexandra Rice; Aurelie Fabre; William A Wallace; Siobhan Nicholson; Alex Haragan; Phillipe Taniere; Andrew G Nicholson; Gavin Laing; Judith Cave; Martin D Forster; Fiona Blackhall; John Gosney; Sanjay Popat; Keith M Kerr
Journal:  Br J Cancer       Date:  2021-09-06       Impact factor: 9.075

3.  MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancer.

Authors:  Lauren MacDonagh; Michael F Gallagher; Brendan Ffrench; Claudia Gasch; Steven G Gray; Marie Reidy; Siobhan Nicholson; Niamh Leonard; Ronan Ryan; Vincent Young; John J O'Leary; Sinead Cuffe; Stephen P Finn; Kenneth J O'Byrne; Martin P Barr
Journal:  Transl Lung Cancer Res       Date:  2021-04

4.  Clinical characteristics and prognosis of pulmonary large cell carcinoma: A population-based retrospective study using SEER data.

Authors:  Liu Xiaochuan; Yu Jiangyong; Zhang Ping; Wu Xiaonan; Li Lin
Journal:  Thorac Cancer       Date:  2020-04-16       Impact factor: 3.500

Review 5.  Multiple faces of pulmonary large cell neuroendocrine carcinoma: update with a focus on practical approach to diagnosis.

Authors:  Marina K Baine; Natasha Rekhtman
Journal:  Transl Lung Cancer Res       Date:  2020-06

6.  Pulmonary large cell carcinoma, highly positive for PD-L1, shows marked response to pembrolizumab: A case report.

Authors:  Naoyuki Okabe; Hayato Mine; Hironori Takagi; Masayuki Watanabe; Satoshi Muto; Yuki Matsumura; Yutaka Shio; Hiroyuki Suzuki
Journal:  Thorac Cancer       Date:  2021-02-19       Impact factor: 3.500

7.  Pulmonary large cell carcinoma with neuroendocrine morphology shows genetic similarity to large cell neuroendocrine carcinoma.

Authors:  Zuoyu Liang; Weiya Wang; Qianrong Hu; Ping Zhou; Ying Zhang; Yuan Tang; Qian Wu; Yiyun Fu; Xue Li; Yang Shao; Lili Jiang
Journal:  Diagn Pathol       Date:  2022-02-10       Impact factor: 2.644

8.  Comprehensive Characterization of Human Lung Large Cell Carcinoma Identifies Transcriptomic Signatures with Potential Implications in Response to Immunotherapy.

Authors:  Javier Ramos-Paradas; David Gómez-Sánchez; Aranzazu Rosado; Alvaro C Ucero; Irene Ferrer; Ricardo García-Luján; Jon Zugazagoitia; Nuria Carrizo; Ana B Enguita; Esther Conde; Eva M Garrido-Martin; Luis Paz-Ares
Journal:  J Clin Med       Date:  2022-03-09       Impact factor: 4.241
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.